GenSight Biologics to participate in multiple upcoming investor conferences

Salon Actionaria 2018, Paris, France

Chardan 2nd Annual Genetic Medicines Conference, NYC (US)

GenSight Biologics Reports Interim Financial Results for the First Half of 2018

Ophthalmology Innovation Summit @ RETINA, Vancouver (BC), Canada

GenSight Biologics reports €49 million cash position as of March 31, 2018 and provides update on GS010

GenSight Biologics Reports Full Year 2017 Financial Results

GenSight Biologics reports €55 million 2017 year-end cash position and provides corporate update

GenSight Biologics Appoints Julio Benedicto as Vice President of Marketing

GenSight Biologics to Participate in Multiple Conferences in November